Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.03
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $6.6M | $4.4M | $4.3M | $4.6M | $4.9M | $5.1M | $2.9M |
| Cost of revenue | $3.4K | $1.2M | $715.2K | $1.0M | $1.2M | $1.0M | $1.3M | $566.9K |
| Gross profit | −$3.4K | $5.4M | $3.7M | $3.3M | $3.4M | $3.9M | $3.7M | $2.3M |
| Gross margin | — | 81.5% | 83.7% | 76.3% | 74.5% | 79.6% | 73.8% | 80.3% |
| R&D | $0 | $936 | $750 | $0 | $0 | $13.8K | $0 | $0 |
| Operating income | −$24.8K | −$2.6M | −$1.4M | −$3.2M | −$5.0M | −$4.2M | −$2.4M | −$2.7M |
| EBITDA | −$21.4K | −$2.2M | −$1.4M | $1.5M | −$4.0M | $48.8K | −$1.8M | −$2.5M |
| Net income | −$37.3K | −$2.8M | −$1.7M | −$15.3M | −$8.6M | −$5.4M | −$3.8M | −$4.0M |
| Net margin | — | -42.2% | -39.4% | -353.7% | -189.3% | -110.3% | -74.6% | -140.7% |
| EPS (diluted) | -0.07 | -0.52 | -3.20 | -0.41 | -0.19 | -0.07 | -0.03 | -0.02 |
Annual figures · source: Financial Modeling Prep
STEMTECH CORP
No one on the platform currently holds STEK.
No tracked institution reports a position in STEK as of their last filing.
No one on the platform has traded STEK yet.
| $522633 |
| — |
| GRPSGold River Productions, Inc. | $0.00 | +0.00% | $361185 | — |
| NRXCFNeutriSci International Inc. | $0.00 | +0.00% | $653980 | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Trading at 0.0× sales vs its 1.3× historical median P/S.
Fair value ≈ $0.05 · price $0.00 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$STEK $FITY Setting up for big moves, restructuring foundatio, like what i see here.
View on StockTwits ↗@walfofwallstreet $STEK otc stock next for 10000%
View on StockTwits ↗$STEK be patient, meanwhile take a look at $FITY is on the move..
View on StockTwits ↗$IOVA Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ) The Best Penny Stock to Buy Before It Explodes.☄️ Iovance has the first #FDA-approved drug for cellular therapy for a solid tumor #cancer called Amtagvi. Target price on Iovance is $14. Current price $3.46 $IBRX $BFLY $PFE $STEK https://finance.yahoo.com/news/iovance-iova-best-penny-stock-062028121.html
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.